首页 | 本学科首页   官方微博 | 高级检索  
     

非普拉宗与泌尿灵联用治疗慢性非细菌性前列腺炎和前列腺痛的疗效观察
引用本文:徐英民,高维忠,夏术阶,张京东,孟凡敏,熊升远. 非普拉宗与泌尿灵联用治疗慢性非细菌性前列腺炎和前列腺痛的疗效观察[J]. 中华男科学杂志, 1996, 0(1)
作者姓名:徐英民  高维忠  夏术阶  张京东  孟凡敏  熊升远
作者单位:山东沂水中心医院泌尿外科,山东省立医院泌尿外科
摘    要:
将156例慢性非细菌性前列腺炎和前列腺痛病人随机分为三组,①A组51例,年龄28±8岁,给予泌尿灵400mg,2次/d;②B组49例,年龄27±10岁,给予非普拉宗200mg,2次/d;③C组56例,年龄30±7岁,给予泌尿灵400mg加非普拉宗200mg,2次/d。结果示,C组总有效率83.9%,与A组(64.7%)和B组(61.3%)比较,差异显著(P<0.05,P<0.01)。A组在改善尿流率指标方面比B组好,但B组解除临床症状比A组好,C组在改善尿流率指标和解除临床症状方面均优于A与B组。

关 键 词:非普拉宗,泌尿灵,前列腺炎,前列腺痛

Effect of feprazoni and genurin in the treatment of chronic nobacterial prostatitis and prostatodynia
Xu Yinmin, Gao Weizhong, Xia Shujie et al. Effect of feprazoni and genurin in the treatment of chronic nobacterial prostatitis and prostatodynia[J]. National journal of andrology, 1996, 0(1)
Authors:Xu Yinmin   Gao Weizhong   Xia Shujie et al
Abstract:
patients with chronic nobacterial prostatitis and prostatodynia were divided into 3 groups: Group A 51 patients(age 28±8 years) were treated with genurin 400mg bid; Group B 49 patients (age 27±10 years) were treated feprazoni 200mg bid; Group C 56 patients (age 30±7 years) were treated with genurin 400mg bid and feprazoni 200mg bid.Results showed that the total response rate in the group C (83.9 %) was better than that in the group A (64.7 %) and group B (61.3%) (P<0.05 and P<0.01). Uroflow rates in the group A were improved after treatment was better than that of the group B. Clinical symptom vanished after treatment in the group B was better than that of the group A. Uroflow rates in the group C were better improved after treatment. So it is better to vanish clinical symptom in the group C. Conclusion:The group C was the best.
Keywords:feprazoni genurin chronic nobacterial prostatitis prostatodynia
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号